Open AccessEradication of minimal residual disease during graft‐versus‐host reaction induced by abrupt discontinuation of immunosuppression following bone marrow transplantation in a patient with Ph 1 ‐ALL
Author(s) -
Kanamori H.,
Sasaki S.,
Yamazaki E.,
Ueda S.,
Tamura T.,
Harano H.,
Ogawa K.,
Mohri H.,
Okubo T.,
Hattori M.,
Fukawa H.,
Matsuzaki M.
Publication year - 1997
Publication title -
transplant international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.998
H-Index - 82
eISSN - 1432-2277
pISSN - 0934-0874
DOI - 10.1111/j.1432-2277.1997.tb00712.x
Subject(s) - medicine , minimal residual disease , immunosuppression , immunology , transplantation , bone marrow , graft versus host disease , leukemia , methotrexate , discontinuation , gastroenterology
. We observed a patient in whom graft‐versus‐host disease (GVHD) appeared to induce a positive effect. This 32‐year‐old male with Philadelphia chromosome‐positive acute lymphoblastic leukemia received a bone marrow transplant (BMT) from an HLA‐identical sibling donor. We analyzed the bone marrow with the reverse transcriptase‐polymerase chain reaction to screen for the minor bcr/abl transcript, which indicates the presence of minimal residual disease (MRD). MRD was present in the pre‐and post‐transplant phases. There was no evidence of acute GVHD by post‐transplant day 45. We abruptly discontinued the immunosuppressive therapy in an attempt to eliminate MRD by inducing an antileukemic reaction during GVHD. GVHD associated with diarrhea and liver dysfunction developed on day 64. On day 105, MRD disappeared and GVHD was treated with prednisolone and cyclosporin. The disappearance of MRD may have been due to the graft‐versus‐leuke‐mia (GVL) effect mediated by the alloimmune response of donor T lymphocytes. These findings suggest that induction of the GVL effect may be useful for eliminating MRD after BMT in leukemia patients at high risk of recurrence of the disease.